Suppr超能文献

德国和瑞典癌症登记处中特定首次原发性癌症后合并的第二种不一致原发性癌症的分布及风险

Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries.

作者信息

Chen Tianhui, Fallah Mahdi, Jansen Lina, Castro Felipe A, Krilavicuite Agne, Katalinic Alexander, Eisemann Nora, Emrich Katharina, Holleczek Bernd, Geiss Karla, Eberle Andrea, Sundquist Jan, Brenner Hermann, Hemminki Kari

机构信息

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.

出版信息

Cancer Lett. 2015 Dec 1;369(1):152-66. doi: 10.1016/j.canlet.2015.08.014. Epub 2015 Aug 28.

Abstract

We aimed at investigating the distribution and risk of all second discordant primary cancers (SDPCs) after a specific first primary cancer in Germany and Sweden to provide etiological understanding of SDPCs and insight into their incidence rates and recording practices. Among 1,537,004 survivors of first primary cancers in Germany and 588,103 in Sweden, overall 80,162 and 32,544 SDPCs were recorded, respectively. Standardized incidence ratios (SIRs) of all SDPCs were elevated at levels between 1.1 and 2.1 after 23 (out of overall 29) cancers in Germany and at levels between 1.1 and 1.6 after 24 cancers in Sweden, and among them, elevated SIRs were found after 19 cancers in both populations. Decreased SIRs at levels ranging from 0.5 to 0.9 were found for some cancers with poor prognosis in Germany only. We found elevated risk after 19 out of 29 cancers in both countries, suggesting common etiology of SDPCs after most of first cancers and registration similarity. Decreased risks after some fatal cancers were found only in Germany, which may be attributed to reporting practices or missed death data in Germany.

摘要

我们旨在调查德国和瑞典特定原发性癌症后所有第二原发性不一致癌症(SDPCs)的分布和风险,以提供对SDPCs的病因学理解,并深入了解其发病率和记录方法。在德国的1,537,004名原发性癌症幸存者和瑞典的588,103名幸存者中,分别记录了80,162例和32,544例SDPCs。德国29种癌症中的23种(共29种)后,所有SDPCs的标准化发病率(SIRs)在1.1至2.1之间升高,瑞典24种癌症后在1.1至1.6之间升高,其中,两国19种癌症后均发现SIRs升高。仅在德国,某些预后不良的癌症的SIRs在0.5至0.9之间降低。我们发现两国29种癌症中有19种癌症后风险升高,这表明大多数原发性癌症后SDPCs的共同病因和登记相似性。仅在德国发现某些致命癌症后的风险降低,这可能归因于德国的报告做法或遗漏的死亡数据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验